Copyright
©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 234-254
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.234
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.234
Figure 4 Tongxinluo restored endothelial cell structure and regulated endothelial nitric oxide synthase, vascular endothelial growth factor, nitric oxide, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 expression.
A: Representative images showing H&E staining of the aortas of mice (400×, bar = 50 μm); B-D: Western blot analysis of the expression of endothelial cell function-related proteins eNOS and VEGF in mice; E: Nitric oxide (NO) kit to detect NO levels in mouse serum; F and G: Immunochemical staining of intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in the ischemic adductor (400×, bar = 50 μm); H and I: Quantification of the percentage areas of ICAM-1 and VCAM-1. The values are shown as the means ± SDs. aP < 0.05 compared with the normal group, bP <0.05 compared with the model group, cP < 0.05 compared with the TXL-L group, n = 3-4. TXL: Tongxinluo; eNOS: Endothelial nitric oxide synthase; VEGF: Vascular endothelial growth factor; ICAM-1: intercellular cell adhesion molecule-1; VCAM-1: Vascular cell adhesion molecule-1; NO: Nitric oxide.
- Citation: Gu JJ, Hou YL, Yan YH, Li J, Wei YR, Ma K, Wang XQ, Zhang JH, Wang DD, Li CR, Li DQ, Sun LL, Gao HL. Tongxinluo promotes endothelium-dependent arteriogenesis to attenuate diabetic peripheral arterial disease. World J Diabetes 2023; 14(3): 234-254
- URL: https://www.wjgnet.com/1948-9358/full/v14/i3/234.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i3.234